Growing community of inventors

Nara-ken, Japan

Keiko Fukushima

Average Co-Inventor Count = 12.55

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 26

Keiko FukushimaKevin Bacon (5 patents)Keiko FukushimaNoriko Nunami (5 patents)Keiko FukushimaKlaus Urbahns (4 patents)Keiko FukushimaToshiya Moriwaki (4 patents)Keiko FukushimaYingfu Li (4 patents)Keiko FukushimaTimothy B Lowinger (3 patents)Keiko FukushimaToshiki Murata (3 patents)Keiko FukushimaTakashi Yoshino (3 patents)Keiko FukushimaMegumi Yamauchi (3 patents)Keiko FukushimaNaoki Tsuno (2 patents)Keiko FukushimaNagahiro Yoshida (2 patents)Keiko FukushimaTakuya Shintani (2 patents)Keiko FukushimaHiromi Sugimoto (2 patents)Keiko FukushimaHiroko Yoshino (2 patents)Keiko FukushimaNorihiro Kawamura (2 patents)Keiko FukushimaMakiko Marumo (2 patents)Keiko FukushimaTetsuo Kikuchi (2 patents)Keiko FukushimaAkihiko Watanabe (2 patents)Keiko FukushimaKentaro Hashimoto (2 patents)Keiko FukushimaRolf Grosser (1 patent)Keiko FukushimaYuji Koriyama (1 patent)Keiko FukushimaKinji Fuchikami (1 patent)Keiko FukushimaHiroki Sato (1 patent)Keiko FukushimaSachiko Sakakibara (1 patent)Keiko FukushimaKatsuko Yamashita (1 patent)Keiko FukushimaShiro Baba (1 patent)Keiko FukushimaKlaus Urbahns (1 patent)Keiko FukushimaKevin Bacon (1 patent)Keiko FukushimaYingfu Li (1 patent)Keiko FukushimaKentaro Hashimoto (1 patent)Keiko FukushimaYuji Hinoda (0 patent)Keiko FukushimaKentaro Hashimoto (0 patent)Keiko FukushimaYoshino Hiroko (0 patent)Keiko FukushimaKevin Bacon (0 patent)Keiko FukushimaKeiko Fukushima (5 patents)Kevin BaconKevin Bacon (12 patents)Noriko NunamiNoriko Nunami (5 patents)Klaus UrbahnsKlaus Urbahns (24 patents)Toshiya MoriwakiToshiya Moriwaki (12 patents)Yingfu LiYingfu Li (6 patents)Timothy B LowingerTimothy B Lowinger (48 patents)Toshiki MurataToshiki Murata (15 patents)Takashi YoshinoTakashi Yoshino (13 patents)Megumi YamauchiMegumi Yamauchi (3 patents)Naoki TsunoNaoki Tsuno (29 patents)Nagahiro YoshidaNagahiro Yoshida (11 patents)Takuya ShintaniTakuya Shintani (10 patents)Hiromi SugimotoHiromi Sugimoto (8 patents)Hiroko YoshinoHiroko Yoshino (3 patents)Norihiro KawamuraNorihiro Kawamura (3 patents)Makiko MarumoMakiko Marumo (3 patents)Tetsuo KikuchiTetsuo Kikuchi (2 patents)Akihiko WatanabeAkihiko Watanabe (2 patents)Kentaro HashimotoKentaro Hashimoto (2 patents)Rolf GrosserRolf Grosser (44 patents)Yuji KoriyamaYuji Koriyama (12 patents)Kinji FuchikamiKinji Fuchikami (8 patents)Hiroki SatoHiroki Sato (7 patents)Sachiko SakakibaraSachiko Sakakibara (5 patents)Katsuko YamashitaKatsuko Yamashita (1 patent)Shiro BabaShiro Baba (1 patent)Klaus UrbahnsKlaus Urbahns (4 patents)Kevin BaconKevin Bacon (2 patents)Yingfu LiYingfu Li (1 patent)Kentaro HashimotoKentaro Hashimoto (1 patent)Yuji HinodaYuji Hinoda (0 patent)Kentaro HashimotoKentaro Hashimoto (0 patent)Yoshino HirokoYoshino Hiroko (0 patent)Kevin BaconKevin Bacon (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Axikin Pharmaceuticals, Inc. (4 from 23 patents)

2. Bayer Healthcare Aktiengesellschaft (1 from 77 patents)

3. Tokyo Institute of Technology (575 patents)

4. Yamaguchi University (86 patents)


5 patents:

1. 9206186 - 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders

2. 8242118 - Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders

3. 7700586 - Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders

4. 7674797 - 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders

5. 7375103 - Optically active pyridine derivative and a medicament containing the same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/9/2026
Loading…